ESC 365 - Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

ESC Premium Access

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Session: Poster Session 3 - Atrial fibrillation - Stroke prevention

Topic: Stroke Prevention, Other

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

0 follower

10 more presentations in this session

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, US)

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Speaker: Assistant Professor H. Yu (Seoul, KR)

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Speaker: Mr S. van der Wall (Haarlem, NL)

The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)

Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study

Speaker: Doctor S. Aeschbacher (Basel, CH)

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention

Speakers: Doctor M. Esteve Pastor, Doctor X. Li, Assistant Professor H. Yu, Mr S. van der Wall, Doctor Z. Salpagarova...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources